Navigation Links
Out of hours doctors reluctant to do home visits, say patients
Date:11/29/2007

ere reluctant to carry out home visits, with many saying that the services discouraged these in favour of getting the patient to come in to a treatment centre.

Picking up medicines out of hours also posed problems, particularly for those in rural areas, or those that did not have a car.

Around 13% of people in England use an out of hours service, say the authors, and most of them tend to be young children, the elderly and people with complex health needs.

Building on their research, the researchers have also developed a questionnaire which, they propose, should be widely used in monitoring patients experience of out of hours care.


'/>"/>

Contact: Andrew Gould
media@pr-works.co.uk
01-392-686-107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Limiting Residents Hours Has Little Impact on Patient Mortality
2. Study finds limiting work hours for surgical residents enhances training
3. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
4. Crossfit Workout Challenge Raises Over $500,000 in Four Hours for Athletes for a Cure
5. Pelosi: In 48 Hours, Congress Must Choose Between Meeting the Needs of Americas Children or Not
6. UK junior doctors gaining less experience of common procedures
7. Doctors Often Miss High Blood Pressure in Kids
8. One-fourth of HIV patients believe their doctors stigmatize them
9. Annual flu shot cuts need for doctors visits, hospitalization among children
10. Teens need to see their doctors more often
11. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...f St. Jude study could shape new treatments for se...RNewswire-USNewswire/ -- Scientists at St. Jude Ch...e effective treatment for bacterial pneumonia foll...lindamycin and azithromycin, which kill bacteria b...ective than a standard first-line treatment with t...
(Date:1/8/2009)...t lowered bad cholesterol more effectively than Zo...) -- After nearly a year of review, U.S. health of...inued use of the controversial cholesterol-lowerin...stration said there was no significant difference ...g Vytorin and patients taking the drug Zocor. ,...
(Date:1/8/2009)... Md., Jan. 8 Hanger Ort...nnounce that throughout the fourth quarter of 2008...Center, Rocky Mountain Orthotic-Prosthetics Center...c., First Coast Orthotics & Prosthetics, and O...isitions add patient care centers to existing mark...
(Date:1/8/2009)...RANCISCO, Jan. 8 Medivat...David Hung, M.D., president and chief,executive o...n Healthcare,Conference on Wednesday, January 14,...ncis Hotel in San Francisco. , Dr. Hung wil...al,development programs for Dimebon for Alzheimer...
Breaking Medicine News(10 mins):Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
...s and sweets is linked to a rise in breast cancer ... a study by US and Chinese researchers released Tu...rom the 1990s Shanghai Breast Cancer Study by Vand...chers found in the new study a correlation between...
...ls two vices. United States FDA-approved smoking ...nded out to alcoholics as well . The Pfizer manu...has been used quite successfully by smokers , was ...e effects in alcoholics too, of the furry kind, la...
...e been substantial savings in drug costs since the...o prescribe the recommended first-line treatment f...h 2004, family doctors have been reimbursed for dr...des as first-line therapy for uncomplicated hypert...
...ish dishes like koi-pla puts people in SE Asia at ... of liver cancer called cholangiocarcinoma (cance...s PLoS Medicine. Banchob Sripa (Khon Kaen Univers...sms by which the food-borne trematode Opisthorchis...
Other Medicine News:Health News:Two In One Drug For Smokers And Drinkers 2Health News:Reduction in Drug Costs 2
(Date:1/8/2009)... treated at the initial dose in an ongoing Phase I... decline after three days , , Conference Call T...wswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. ... first cohort of an ongoing Phase Ib clinical tria...leoside polymerase inhibitor. ANA598 was very wel...
(Date:1/7/2009)...K, Md., Jan. 7 ImQuest Life Scienc... IND application to the Food and Drug Administrati...d pyrimidinedione HIV inhibitor IQP-0410. ImQuest ...e first quarter of 2009. IQP-0410 is a novel small... a nonnucleoside reverse transcriptase inhibitor (...
(Date:1/6/2009)...Expands on Successful Results from prior U.S., U.K...swire/ -- Vital Therapies, Inc. (VTI), a developme...nounced patient enrollment has begun for a randomi...ial that will study the Extracorporeal Liver Assis...cute Liver Failure (ALF) under three protocols. Th...
(Date:1/6/2009)...E, Md., Jan. 6 Sequella... focused on diseases of epidemic potential, announ...the treatment of tuberculosis (TB), was the first ...inical program contract to Dynport Vaccine Company...arded by the National Institute of Allergy and Inf...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Aspreva receives final court approval for acquisition by Galenica 8509 1Aspreva receives final court approval for acquisition by Galenica 8509 2Aspreva receives final court approval for acquisition by Galenica 8509 3Aspreva receives final court approval for acquisition by Galenica 8509 4Alsius Corporation Announces Program for Early Exercise of Warrants 8507 1Alsius Corporation Announces Program for Early Exercise of Warrants 8507 2Alsius Corporation Announces Program for Early Exercise of Warrants 8507 3Alsius Corporation Announces Program for Early Exercise of Warrants 8507 4New neuroimaging study identifies brain signature for cigarette cravings 8506 1New neuroimaging study identifies brain signature for cigarette cravings 8506 2Cumberland Pharmaceuticals Announces Appointments 8504 1Cumberland Pharmaceuticals Announces Appointments 8504 2
...SCO confirm safety findings,and demonstrate clinic...ectal and other types of cancer., PRINCETON, N.J.,...cals announced positive safety and efficacy result...Floxuridine), Liposome,Injection in patients with ...s were presented yesterday in a poster presentatio...
...(CSE: GEN) announced,today pre-clinical data illus...umab) antibody may have broad potential,to treat c...idermal,growth factor receptor). , Recently, mutat...f EGFr have been identified in tumors from lung ca...ctor in the potential success of,EGFr-directed tre...
Other Medicine Technology:Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 2Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 3
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: